NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Epithelix

Epithelix

Private
Plan-les-OuatesHealthcare & Life Scienceshttps://epithelix.com/

Last Round

Grant

Dec 1, 2020

Total Funding Raised

$146,100

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Epithelix is a biotechnology company that provides alternative in-vitro solutions to animal experimentation for evaluating the effects of drugs and the toxicity of chemical compounds on the human respiratory tract.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

3D tissue modelhuman respiratory tissueanimal testing alternativein vitro model3D cell culturecontract research organizationCROtoxicity testingtissue engineeringpreclinical researchair-liquid interface cultureinhalation toxicityrespiratory disease modelprimary human cellorgan-on-a-chip

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Epithelix Comparables

Compare Epithelix with similar companies based on industry and business-model similarity.

Epithelix comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Epithelix Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantDec 1, 2020
GrantJun 18, 2008
GrantJun 18, 2007
SeedMar 1, 2006

Key People

Founding team and executive leadership

ludovic wiszniewski

CEO

Executive Team

Samuel Constant

Co-founder And Chief Executive Officer

Founding Team

Epithelix Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 16, 2026

    Monthly visitors grew 40% MoM, reaching 1.6K.

  • Apr 15, 2026

    Monthly visitors increased 2440% MoM, reaching 1.1K.

Epithelix Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Epithelix Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Epithelix's valuation, stock price, and market status.

Firmographic Details

HeadquartersPlan-les-Ouates
Employee Range18
Year Founded2006
Last FundingDec 1, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.